Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2338283
Max Phase: Preclinical
Molecular Formula: C36H40N4O6
Molecular Weight: 624.74
Molecule Type: Small molecule
Associated Items:
ID: ALA2338283
Max Phase: Preclinical
Molecular Formula: C36H40N4O6
Molecular Weight: 624.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=C/C(=O)NC[C@H]2c3cc(OC)c(OC)cc3C[C@H]3[C@H]4c5cc(OC)c(OC)cc5C[C@@H]([C@H](C#N)N23)N4C)cc1
Standard InChI: InChI=1S/C36H40N4O6/c1-39-27-13-23-16-32(44-4)34(46-6)18-26(23)36(39)28-14-22-15-31(43-3)33(45-5)17-25(22)30(40(28)29(27)19-37)20-38-35(41)12-9-21-7-10-24(42-2)11-8-21/h7-12,15-18,27-30,36H,13-14,20H2,1-6H3,(H,38,41)/b12-9+/t27-,28-,29-,30-,36+/m0/s1
Standard InChI Key: JYNWSMKFFKRFBT-UAHWUMLOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 624.74 | Molecular Weight (Monoisotopic): 624.2948 | AlogP: 4.33 | #Rotatable Bonds: 9 |
Polar Surface Area: 105.52 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 4.73 | CX LogP: 4.15 | CX LogD: 4.14 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.35 | Np Likeness Score: 0.55 |
1. Guo J, Dong W, Liu W, Yan Z, Wang N, Liu Z.. (2013) Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa., 62 [PMID:23434640] [10.1016/j.ejmech.2013.01.033] |
Source(1):